Wickham Micro

What Wickham Micro does

Wickham Micro is a United Kingdom-based GMP/GLP compliant contract testing laboratory founded in 1962 with 101-250 employees, operating as a wholly-owned testing laboratory within the Cormica group. The company provides specialised microbiology testing services to pharmaceutical and medical device manufacturers, organised into three core service lines: Medical Devices Testing (biocompatibility, cytotoxicity, bioburden, microbial identification, sterility testing, microbial ingress, reprocessing validation), Pharmaceutical Product Testing (stability storage and testing, quality control, method validation, antimicrobial efficacy, bacterial endotoxin testing), and General Microbiology (biological indicator testing, environmental monitoring, disinfectant efficacy, autoclave qualification, process validation). In-vitro services include Bacterial Endotoxin Testing using the LAL method, cytotoxicity testing, and Monocyte Activation Testing (MAT) as an animal-free pyrogenicity alternative.

The underlying technology relies on validated wet-lab methodologies including Limulus Amebocyte Lysate (LAL) endotoxin detection, Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-ToF) mass spectrometry for microbial identification, and ISO 10993-aligned biocompatibility testing. The laboratory holds GMP compliance, GLP compliance (Statement dated 18 July 2024), and FDA registration (FDA Letter of Approval 2019), enabling it to support client product release testing and regulatory submissions across multiple jurisdictions.

Wickham Micro operates a B2B contract services model on a fee-for-service basis with quote-based pricing determined by test type, sample complexity, and turnaround expectations. The go-to-market motion is consultative, enterprise-focused field sales targeting pharmaceutical and medical device manufacturers globally, supplemented by inbound inquiries via the corporate website and a content marketing programme (white papers, case studies, webinars). In June 2022, Wickham Micro acquired Medical Engineering Technologies (MET) with backing from private equity firm Limerston Capital, expanding its footprint into US and European markets. Named clients include Cantor and Nissel, Touchlight, and Rayner. The company offers expedited testing for time-sensitive product release work.

Name

Wickham Micro

Legal name

Wickham Micro Limited

Website

https://wickhamlabs.co.uk

Company type

Private

Founded year

1964

Operating status

Operating

Headcount range

101–250 employees

Short description

Wickham Micro is a UK-based GMP/GLP compliant contract testing laboratory providing specialised microbiology testing services — including biocompatibility, sterility, endotoxin, and microbial identification — to pharmaceutical and medical device manufacturers worldwide, operating as part of the Cormica testing laboratory group.

Ownership category

akta.pro rank

Product category

Contract Laboratory Testing Services

NAICS

Testing Laboratories and Services (541380), Testing Laboratories and Services (54138)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)

akta.pro secondary industries

Water & Utility Testing (PW/WFI/Steam/Gases) (HLAGADAO), Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

• Contract testing laboratory
• Microbiology testing services
• Medical device testing
• Pharmaceutical testing
• Sterility endotoxin testing

Headquarters

HQ city

Gosport

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Testing Services: Wickham Micro operates as a B2B contract testing laboratory, providing specialized microbiology testing services to pharmaceutical and medical device manufacturers on a fee-for-service basis. Services range from early-stage development testing through to routine quality control and product release testing. Revenue is generated through per-test fees, project-based contracts, and potentially recurring testing agreements with long-term clients.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

Wickham Micro is a GMP/GLP compliant contract testing laboratory providing specialized microbiology testing services to pharmaceutical and medical device manufacturers. It performs sterility, bioburden, endotoxin (LAL), biocompatibility, cytotoxicity, microbial identification, method validation, and stability testing on a fee-for-service basis to support regulatory submissions and product release.

Product overview

Wickham Micro is a GMP/GLP compliant contract testing laboratory offering specialized pharmaceutical and medical device testing services in microbiology. The company operates as a unified portfolio of testing services organized into three core service areas: Medical Devices Testing, Pharmaceutical Product Testing Services, and General Microbiology Testing, with dedicated In-Vitro services including Bacterial Endotoxin Testing (LAL), Cytotoxicity, and Monocyte Activation Testing. In June 2022, Wickham Micro acquired Medical Engineering Technologies (MET), a medical device testing lab, to expand its capabilities in Europe and the U.S. The company has over 60 years of experience serving clients worldwide, providing testing solutions from early-stage development through product release and routine testing services.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Devices Testing Comprehensive microbiology testing services for medical device manufacturers including biocompatibility, quality control, method validation, cytotoxicity, bioburden, microbial ingress, microbial identification, sterility, and reprocessing validation to support ISO 10993 and regulatory compliance.
• Pharmaceutical Product Testing Services Testing services for pharmaceutical manufacturers including stability storage and testing, quality control, method validation, bioburden testing, microbial identification, antimicrobial efficacy, sterility, and bacterial endotoxin testing for drug safety, quality, and release.
• General Microbiology Testing Broad microbiology testing including biological indicator testing, microbial ingress testing, microbial process validation, environmental monitoring, in-vitro testing, in-house media prep, disinfectant efficacy testing, and autoclave qualification for healthcare, research, and manufacturing clients.
• Bacterial Endotoxin Testing (LAL) In-vitro endotoxin detection using the Limulus Amebocyte Lysate (LAL) method to detect pyrogenic contamination in pharmaceutical and medical device products.
• Cytotoxicity Testing (In-Vitro) In-vitro cytotoxicity testing to evaluate potential toxic effects of medical devices and pharmaceutical products on cells.
• Monocyte Activation Testing (MAT) Animal-free in-vitro pyrogenicity testing using human monocytes to detect fever-inducing substances as an alternative to animal-based testing.
• Expedited Testing Services Fast-tracked testing turnaround across the full service range for clients facing delivery pressures and tight deadlines, significantly reducing standard turnaround times depending on sample and test requirements.

Quantifiable outcome

• 60+ years of specialist experience in pharmaceutical and medical device testing
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Medical Engineering Technologies (MET)coreStrategic or Co-development Partner · 15 June 2022Medical Engineering Technologies (MET) is a medical device testing lab that was acquired by Wickham Micro in June 2022 with support from Limerston Capital. The acquisition allows Wickham Micro to expand its capabilities in Europe and the U.S. and to offer full-service validation and testing services, strengthening its position in the medical device and pharmaceutical testing markets.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• SGS: Global testing and certification company with a substantial life sciences laboratory network providing pharmaceutical and medical device microbiology testing at much greater scale, competing directly for enterprise testing contracts.
• Intertek: Operates a global network of contract laboratories serving pharmaceutical and medical device manufacturers with testing, quality assurance, and regulatory support services that overlap Wickham Micro's GMP/GLP testing portfolio.
• BioReliance (Merck KGaA): Provides GMP/GLP-compliant contract testing services for the pharmaceutical and biotech industries including microbial identification, endotoxin, and sterility testing — overlapping Wickham Micro's pharma testing capabilities under a larger parent.
• Eurofins Scientific: Global leader in contract laboratory testing services for pharmaceutical and medical device product testing, with broad microbiology, sterility, and biocompatibility offerings that overlap directly with Wickham Micro's core menu and enterprise customer base.

Direct peers

• Reading Scientific Services Ltd (RSSL): UK-based contract analytical laboratory providing pharmaceutical and biopharmaceutical testing services including microbiology, method validation, and stability — a close regional peer to Wickham Micro.
• Charles River Laboratories: Provides microbiology, endotoxin, sterility, and biocompatibility testing services to pharma and medical device manufacturers globally — directly mirroring Wickham Micro's microbial identification, LAL, and medical device testing offerings.
• Nelson Labs: Specializes in microbiology and medical device testing including sterility, biocompatibility, and endotoxin testing for medical device manufacturers, offering a directly comparable service menu to Wickham Micro.
• Smithers: Contract research organization providing testing and consulting services for pharmaceutical, medical device, and regulatory clients including microbiology and product safety work, comparable to Wickham Micro's service scope.

Emerging players

• Rapid Micro Biosystems: Provides automated rapid microbial detection and identification technology used by pharmaceutical manufacturers — adjacent technology comparison to Wickham Micro's MALDI-ToF and traditional microbiology testing services.

Others

• STITCH Microbiology (Cormica group peer labs): Cormica sibling laboratories within the same parent group as Wickham Micro offer overlapping pharmaceutical and medical device testing capabilities that can both compete for and route client work alongside Wickham Micro.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/WickhamMicro

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wickham Micro